Loading transcript...
Click for full transcript
Chapters & Sections (108)
▼
00:00
US Healthcare System Performance and Chronic Diseases
00:53
Addressing a Broken Healthcare System
01:21
FDA's Impact on Public Health and Wellbeing
01:56
Access to Federal Government Agencies and Healthcare Policy
03:45
FDA Structure and Global Regulatory Responsibilities
05:00
Purpose in Medicine and Addressing Systemic Issues
05:35
Challenging Assumptions in FDA Regulations
07:14
Implementing Change in a Bureaucratic Organization
08:33
FDA Mission and Priorities for Public Health
08:56
FDA Priorities and Regulatory Actions
09:42
Regulatory Reforms in Medical Research and Treatment
10:08
Challenging Settled Science in Medical Establishments
10:55
Medical History and the Status Quo
11:23
Medical Group Think and Dogma in Medicine
12:00
The Altruism of Healthcare Professionals
12:27
The Compassion and Bond of Healthcare Professionals
14:50
Critique of Modern Medical Education and Nutrition
16:48
Lack of Education on Whole Foods and Lifestyle Factors
17:23
Prevention vs Treatment in Healthcare System
19:58
Causes and Consequences of Insulin Resistance
20:41
Critique of Modern Childhood Behavioral Diagnoses
21:19
Overmedication of Children and Societal Consequences
22:24
Rewriting Nutritional Guidelines and Food Pyramid
23:53
Rewriting Dietary Guidelines and Ending Saturated Fat War
24:50
Importance of Whole Foods in Diet
25:16
Revising the Food Pyramid Guidelines
27:47
Criticism of HRT and Scientific Humility
28:17
Manipulation of Medical Study Data and Statistics
31:18
Conflict Over Manuscript on Breast Cancer Link
31:59
Censorship of Scientific Dissent in Research
32:38
Hormone Replacement Therapy Misinformation and Underuse
36:18
Hormone Therapy Effects on Menopause Symptoms
36:44
Normalization of Sleep Patterns in Women
37:07
Role of the Food and Drug Administration
37:35
FDA Commissioner's Vision for Public Health Improvement
39:50
Questioning Excessive COVID Vaccine Recommendations
40:33
Regulatory Changes in Food Industry and Safety
41:09
Regulation Enforcement of Misleading Health Ads
41:46
Liability Shields for Pharmaceutical Companies
42:35
FDA Vaccine Mandates and Investigation
43:31
Reevaluating FDA Vaccine Approval Process
44:22
FDA Decision Making Process and Transparency
46:00
Return to Independent Scientific Policy Making
51:35
Antibiotic Overuse and Microbiome Disruption
52:29
Advancements in Cancer Treatment Therapies
58:53
Regulating Gray Areas in Medical Prescriptions
59:54
FDA Priority Review Process for New Drugs
01:01:56
Regulating Over-the-Counter Medications and Pricing
01:02:52
Medical Tourism and International Treatment Options
01:03:27
Regenerative Medicine Therapies and FDA Regulation
01:04:17
Modernizing FDA Approval Process for New Therapies
01:05:13
Limitations of Randomized Clinical Trials
01:06:02
Long-term Cancer Survivor Success Story
01:06:33
Unforeseen Complications in Cancer Surgery Outcomes
01:07:39
Evaluating the Impact of Food Dyes on Behavior
01:08:38
Risks and Consequences of Ineffective Medical Treatments
01:09:17
Personalized Cancer Treatment Using Immunotherapy
01:09:55
Autologous Stem Cell Therapy for Cancer Treatment
01:15:23
Bureaucratic Challenges in Large Government Agencies
01:16:02
Importance of Transparency in Science and Government
01:16:58
Defining the Ultimate Human and Societal Humility
01:18:28
Access to Power and Decision-Making Influence
01:19:21
Appreciation for Expert Service Provided
55m⏭ 2
1h 4m⏭ 3
1h 14m⏭ 2
1h 54m⏭ 3
1h 11m⏭ 2
47m⏭ 3
1h 19m⏭ 2
1h 35m
1h 3m
1h 28m⏭ 2
1h 24m⏭ 2
21m⏭ 1
1h 20m
3h 13m⏭ 2
48m⏭ 1
1h 40m⏭ 3
31m⏭ 1
1h 22m
1h 16m⏭ 4
1h 50m⏭ 3
47m
18m
4h 6m⏭ 2
2h 15m⏭ 2